AINDEX
Markets

Progyny, Inc. (PGNY)

PGNYStock

$36.18

-0.4000 (-1.09%) today

Last price, Nov 13, 4:00 PM ET

-1.09% 1D
Market cap
–
P/E
33.5
EPS, last 4 quarters
$1.08
Dividend yield
–
Day range
–
52-week range
–
Average volume
–
Previous close
$36.58

Analysts

9 covering

Buy7 buy, 2 hold, 0 sell

Targets a year out average $36.63, +1.2% from here

$35.00now $36.18$38.00

Earnings

next estimate $0.4000

Next report

Dec 2025

+7.7%

Mar 2026

+20.8%

Jun 2026

+21.4%

Sep 2026

+14.8%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$318.40m$328.50m$350.51m$341.25m
Gross profit$76.88m$83.07m$89.30m$83.74m
Operating income$15.22m$35.38m$40.00m$35.18m
Net income$12.48m$24.23m$28.05m$26.25m

Last four quarters: revenue $1.34bn, margin 6.8%, free cash flow $179.64m

News

8 latest

The company

Progyny is a global leader in women's health and family building solutions, trusted by leading employers, health plans, and benefit purchasers worldwide. Through its comprehensive and personalized approach, Progyny supports members across fertility and family building, pregnancy and postpartum, menopause and midlife, and parent and child well-being journeys. Progyny combines differentiated clinical care, integrated pharmacy support through Progyny Rx, and personalized guidance from Progyny Care Advocates to deliver improved member experiences and better health outcomes.

Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Progyny, Inc. (PGNY) price, chart and news · AINDEX